2025 orientation - posed group outside
Teaching and Prevention Through Quality Research

Our department is leading research and prevention activities that impact public health by training students to evaluate and respond to important public health issues in aging and chronic disease prevention, reproductive health, environmental health, and infectious diseases.

Why Study Epidemiology?

News

Natacha DeGenna, PhD, associate professor of psychiatry, clinical and translational science, and epidemiology

Far less than one drink a day could raise your cancer risk, study finds

Having just 0.35 ounces of alcohol per day has been linked to a higher risk of cancers of the pharynx, colon, rectum, esophagus, breast, liver, pancreas and prostate. “If you do the math, the results of this study suggest that it’s not safe to drink even one standard drink every day,” says Natacha DeGenna, PhD, associate professor of psychiatry, clinical and translational science, and epidemiology at the University of Pittsburgh.

Nancy Glynn and others at the ACSM conference

Pitt Public Health students, faculty present at American College of Sports Medicine Annual meeting

Students and faculty in the Department of Epidemiology at the University of Pittsburgh School of Public Health attended the American College of Sports Medicine (ACSM) Annual Meeting held May 25-29 in Salt Lake City, Utah, where they presented research on aging, physical activity and maternal health.

Stephen Wisniewski, professor of epidemiology and co-director of the Epidemiology Data Center at Pitt’s School of Public Health

Nationwide trial: Whole blood and components equally effective in prehospital trauma care

Giving whole blood or the component parts of blood are equally effective options for paramedics and emergency medical technicians to use in treating patients with severe, traumatic bleeding before arriving at the hospital, according to a large, nationwide trial directed by University of Pittsburgh and UPMC clinicians and scientists. “Our thoughtful approach to the study design allowed us to not only answer the important question of the efficacy of whole blood compared to component therapy, but also to evaluate the health impact of an important public health question, the age of whole blood,” said senior author Stephen Wisniewski, PhD, professor of epidemiology and co-director of the Epidemiology Data Center at Pitt’s School of Public Health.